Back translation for molecule generation

Artificial Intelligence Methods and Models for Retro-Biosynthesis: A Scoping Review

Retrosynthesis aims to efficiently plan the synthesis of desirable chemicals by strategically breaking down molecules into readily available building block compounds. Having a long history in chemistry, retro-biosynthesis has also been used in the fields of biocatalysis and synthetic biology. Artificial intelligence (AI) is driving us toward new frontiers in synthesis planning and the exploration of chemical spaces, arriving at an opportune moment for promoting bioproduction that would better align with green chemistry, enhancing environmental practices. In this review, we summarize the recent advancements in the application of AI methods and models for retrosynthetic and retro-biosynthetic pathway design. These techniques can be based either on reaction templates or generative models and require scoring functions and planning strategies to navigate through the retrosynthetic graph of possibilities. We finally discuss limitations and promising research directions in this field.

COMA: efficient structure-constrained molecular generation using contractive and margin losses

BACKGROUND

Structure-constrained molecular generation is a promising approach to drug discovery. The goal of structure-constrained molecular generation is to produce a novel molecule that is similar to a given source molecule (e.g. hit molecules) but has enhanced chemical properties (for lead optimization). Many structure-constrained molecular generation models with superior performance in improving chemical properties have been proposed; however, they still have difficulty producing many novel molecules that satisfy both the high structural similarities to each source molecule and improved molecular properties.

METHODS

We propose a structure-constrained molecular generation model that utilizes contractive and margin loss terms to simultaneously achieve property improvement and high structural similarity. The proposed model has two training phases; a generator first learns molecular representation vectors using metric learning with contractive and margin losses and then explores optimized molecular structure for target property improvement via reinforcement learning.

RESULTS

We demonstrate the superiority of our proposed method by comparing it with various state-of-the-art baselines and through ablation studies. Furthermore, we demonstrate the use of our method in drug discovery using an example of sorafenib-like molecular generation in patients with drug resistance.

Powerful molecule generation with simple ConvNet

Motivation

Automated molecule generation is a crucial step in in-silico drug discovery. Graph-based generation algorithms have seen significant progress over recent years. However, they are often complex to implement, hard to train and can under-perform when generating long-sequence molecules. The development of a simple and powerful alternative can help improve practicality of automated drug discovery method.

Results

We proposed a ConvNet-based sequential graph generation algorithm. The molecular graph generation problem is reformulated as a sequence of simple classification tasks. At each step, a convolutional neural network operates on a sub-graph that is generated at previous step, and predicts/classifies an atom/bond adding action to populate the input sub-graph. The proposed model is pretrained by learning to sequentially reconstruct existing molecules. The pretrained model is abbreviated as SEEM (structural encoder for engineering molecules). It is then fine-tuned with reinforcement learning to generate molecules with improved properties. The fine-tuned model is named SEED (structural encoder for engineering drug-like-molecules). The proposed models have demonstrated competitive performance comparing to 16 state-of-the-art baselines on three benchmark datasets.

Availability and implementation

Code is available at https://github.com/yuh8/SEEM and https://github.com/yuh8/SEED. QM9 dataset is availble at http://quantum-machine.org/datasets/, ZINC250k dataset is availble at https://raw.githubusercontent.com/aspuru-guzik-group/chemical_vae/master/models/zinc_properties/250k_rndm_zinc_drugs_clean_3.csv, and ChEMBL dataset is availble at https://www.ebi.ac.uk/chembl/.

Supplementary information

Supplementary data are available at Bioinformatics online.